StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a research note issued on Thursday. The firm set a "hold" rating on the stock.
Separately, Benchmark reiterated a "speculative buy" rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.
Check Out Our Latest Stock Report on MLSS
Milestone Scientific Stock Performance
Shares of NYSE MLSS traded down $0.02 during trading on Thursday, reaching $0.83. The company had a trading volume of 18,276 shares, compared to its average volume of 115,019. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.10. The business's 50 day moving average price is $0.82 and its 200-day moving average price is $0.86. The stock has a market cap of $64.65 million, a PE ratio of -12.14 and a beta of 1.10.
Insider Activity
In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the business's stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares of the company's stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 109,193 shares of company stock valued at $101,634 in the last ninety days. 24.75% of the stock is owned by insiders.
Institutional Investors Weigh In On Milestone Scientific
Several institutional investors have recently added to or reduced their stakes in the stock. Y Intercept Hong Kong Ltd acquired a new position in shares of Milestone Scientific during the third quarter worth about $48,000. World Investment Advisors LLC bought a new stake in shares of Milestone Scientific in the third quarter worth $91,000. Finally, Geode Capital Management LLC boosted its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. 5.79% of the stock is owned by institutional investors.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Articles
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
